Le Bail B, Bernard P H, Carles J, Balabaud C, Bioulac-Sage P
Laboratoire de Pathologie-Groupe de Recherche pour l'Etude du Foie, Université Bordeaux 2, France.
J Hepatol. 1997 Nov;27(5):835-42. doi: 10.1016/s0168-8278(97)80321-2.
BACKGROUND/AIMS: Liver cell dysplasia of large (LLCD) and small (SLCD) cell types may represent a premalignant change. We sought to evaluate their prevalence, relationship with the gross type of cirrhosis, aetiology of liver disease, and the presence of hepatocellular carcinoma in a series of cirrhotic livers.
The presence and pattern of SLCD and LLCD were evaluated by careful histological analysis in 100 consecutive cirrhotic livers of viral (49%) or non viral (51%) aetiology, and with or without hepatocellular carcinoma. Prevalences were compared using Chi-square or Fisher's tests; relative risk for hepatocellular carcinoma was evaluated by the odds ratio.
Dysplasia was found in 82/100 of livers. Eighty-one had LLCD, with (n=49) or without (n=32) associated SLCD. SLCD alone was found in only one case. LLCD and SLCD tended to be more frequent and extensive in mixed or macronodular cirrhosis than in micronodular cirrhosis. LLCD was significantly more frequent and extensive in cirrhosis due to hepatitis B, as was SLCD in cirrhosis due to hepatitis B virus or biliary diseases, where it showed a different pattern (focal vs diffuse, respectively). LLCD and SLCD were both significantly associated with the presence of hepatocellular carcinoma, even of small size. Small foci of SLCD and widespread LLCD were the two conditions which showed the strongest association with hepatocellular carcinoma, with odds ratios of: 6.33 and 3.88, respectively. Widespread SLCD was not relevant for hepatocellular carcinoma in biliary diseases.
Liver cell dysplasia may be considered an additional risk factor for hepatocellular carcinoma in patients with cirrhosis and should be looked for in biopsies. Widespread LLCD and SLCD with a focal pattern are particularly relevant for hepatocellular carcinoma, whereas widespread small cell changes found in biliary diseases seem to have a different biological significance.
背景/目的:大细胞型(LLCD)和小细胞型(SLCD)肝细胞发育异常可能代表一种癌前改变。我们试图评估它们在一系列肝硬化肝脏中的发生率、与肝硬化大体类型的关系、肝病病因以及肝细胞癌的存在情况。
通过仔细的组织学分析,对100例连续的病毒病因(49%)或非病毒病因(51%)的肝硬化肝脏进行评估,这些肝脏有无肝细胞癌。使用卡方检验或费舍尔检验比较发生率;通过比值比评估肝细胞癌的相对风险。
在100例肝脏中有82例发现发育异常。81例有LLCD,伴有(n = 49)或不伴有(n = 32)相关的SLCD。仅1例发现单独的SLCD。LLCD和SLCD在混合性或大结节性肝硬化中往往比在小结节性肝硬化中更频繁且更广泛。LLCD在乙型肝炎所致肝硬化中明显更频繁且更广泛,SLCD在乙型肝炎病毒或胆汁性疾病所致肝硬化中也是如此,且呈现不同模式(分别为局灶性与弥漫性)。LLCD和SLCD均与肝细胞癌的存在显著相关,即使是小肝癌。SLCD的小病灶和广泛的LLCD是与肝细胞癌关联最强的两种情况,比值比分别为6.33和3.88。广泛的SLCD与胆汁性疾病中的肝细胞癌无关。
肝细胞发育异常可被视为肝硬化患者肝细胞癌的一个额外危险因素,应在活检中予以查找。广泛的LLCD和局灶性模式的SLCD与肝细胞癌特别相关,而在胆汁性疾病中发现的广泛小细胞改变似乎具有不同的生物学意义。